BODIPY-FL Nilotinib (Tasigna) for Use in Cancer Research

BODIPY-FL Nilotinib (Tasigna) for Use in Cancer Research

Provided by: National Institutes of Health (NIH)
Tags: anti-cancer cancer Breast Cancer GPCR Cell Line
Short Description:

This technology pertains to bodipy conjugated tyrosine kinase inhibitors that are currently used in the clinic for the treatment of CML or gastric cancers.

Projects based on this Technology

Start New Project